Restatement of Previously Issued Unaudited Condensed Financial Statements for the Three Months Ended May 31, 2021 (Details) - Schedule of the company’s previously issued balance	3 Months Ended
	May 31, 2021 USD ($)
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Accrued expenses (including accrued interest)	$ 1,529,273
Note payable	246,360
Derivative warrant liability
Common stock	7,297
Additional paid-in capital	446,555,737
Accumulated deficit	(466,992,328)
Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Accrued expenses (including accrued interest)	(92,625)
Note payable
Derivative warrant liability	1,238,955
Common stock
Additional paid-in capital	(136,004)
Total liabilities	258,636
Share-based compensation addition	16,934
Accumulated deficit	(1,238,955)
Total stockholders’ deficit	136,004
Total liabilities and stockholders’ deficit	(258,636)
Share-based compensation expense	(16,934)
Payroll compensation expense	92,626
Reclassifications [Member]
Condensed Financial Statements, Captions [Line Items]
Accrued expenses (including accrued interest)	5,125
Note payable	(5,125)
Derivative warrant liability
Common stock	(2)
Additional paid-in capital	2
Total liabilities
Accumulated deficit
Total stockholders’ deficit
Total liabilities and stockholders’ deficit
Share-based compensation expense
Payroll compensation expense
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Accrued expenses (including accrued interest)	1,441,772
Note payable	241,235
Derivative warrant liability	1,238,955
Common stock	7,295
Additional paid-in capital	446,695,305
Accumulated deficit	$ (468,278,223)